MUSE cells have gained attention for their regenerative potential without tumor risk, unlike other pluripotent stem cells. This newsletter offers a critical review of their biology, clinical evidence, and the misuse of the MUSE label in…
Lee mas...

Monoclonal antibodies (mAbs) have revolutionized diagnostic and therapeutic medicine through their molecular specificity. This article explores their origin in humoral immunity, the differences between polyclonal and monoclonal responses,…
Lee mas...

Mesenchymal Stromal Cell (MSC) therapies bring renewed hope for treating various conditions. This practical guide outlines what to expect before, during, and after therapy, including preparation, clinical indications, potential effects, and…
Lee mas...

Cell therapy management extends beyond cultivation. Delivery and storage are critical phases that can directly impact treatment quality and effectiveness. This article explores factors such as cell concentration, gravitational aggregation,…
Lee mas...

CAR-T cell therapy is one of the most groundbreaking developments in cancer immunotherapy. By genetically modifying a patient's T cells, this treatment targets specific cancer antigens with precision. While successful in certain hematologic…
Lee mas...